Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Sociedad Química y Minera de Chile
SQM
$20.4B
| $50.7M | 0.01% |
606,721
+254,877
| +72% | +$22.4M |
|
|
PDCO
977
DELISTED
Patterson Companies, Inc.
PDCO
| $50.4M | 0.01% |
1,663,960
+1,013,240
| +156% | +$31.7M |
|
978
CALL
Hershey
HSY
$37B
| $50.3M | 0.01% |
234,000
+155,800
| +199% | +$34M |
|
979
PUT
Trade Desk
TTD
$6.84B
| $50.3M | 0.01% |
1,201,800
-1,012,300
| -46% | -$55.4M |
|
980
CALL
US Bancorp
USB
$101B
| $50.3M | 0.01% |
1,093,400
-446,300
| -29% | -$22.3M |
|
981
Xenon Pharmaceuticals
XENE
$6.31B
| $50.1M | 0.01% |
1,648,039
+206,959
| +14% | +$6.26M |
|
982
Tradeweb Markets
TW
$21.9B
| $49.9M | 0.01% |
731,696
+472,147
| +182% | +$34.3M |
|
983
CALL
VanEck Junior Gold Miners ETF
GDXJ
$8.33B
| $49.9M | 0.01% |
1,560,200
-399,000
| -20% | -$16.4M |
|
|
COUP
984
CALL
DELISTED
Coupa Software Incorporated
COUP
| $49.9M | 0.01% |
873,200
-188,400
| -18% | -$14.5M |
|
985
PUT
O'Reilly Automotive
ORLY
$74.5B
| $49.7M | 0.01% |
1,180,500
+523,500
| +80% | +$22.5M |
|
986
CALL
Enbridge
ENB
$112B
| $49.7M | 0.01% |
1,175,400
-37,600
| -3% | -$1.68M |
|
987
CALL
C.H. Robinson
CHRW
$17.1B
| $49.7M | 0.01% |
489,800
-54,000
| -10% | -$5.64M |
|
|
UNVR
988
DELISTED
Univar Solutions Inc.
UNVR
| $49.6M | 0.01% |
1,996,270
+1,758,043
| +738% | +$51.7M |
|
989
Ryman Hospitality Properties
RHP
$7.82B
| $49.6M | 0.01% |
652,710
+86,411
| +15% | +$7.62M |
|
|
NVO
990
Novo Nordisk
NVO
$205B
| $49.5M | 0.01% |
888,404
+775,046
| +684% | +$43M |
|
991
PUT
AstraZeneca
AZN
$244B
| $49.4M | 0.01% |
373,726
+44,306
| +13% | +$5.81M |
|
992
PUT
Advance Auto Parts
AAP
$3.23B
| $49.1M | 0.01% |
283,600
+129,600
| +84% | +$25.7M |
|
993
PUT
Estee Lauder
EL
$31.6B
| $49M | 0.01% |
192,300
-36,200
| -16% | -$9.18M |
|
994
CALL
DraftKings
DKNG
$12.7B
| $48.9M | 0.01% |
4,192,972
+638,372
| +18% | +$8.99M |
|
995
Copa Holdings
CPA
$6.14B
| $48.8M | 0.01% |
770,338
-13,976
| -2% | -$985K |
|
996
Ferguson
FERG
$47.4B
| $48.8M | 0.01% |
440,588
+390,952
| +788% | +$47.3M |
|
997
Pfizer
PFE
$153B
| $48.7M | 0.01% |
929,600
-499,168
| -35% | -$25.4M |
|
|
MNDT
998
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $48.7M | 0.01% |
2,230,053
+1,175,272
| +111% | +$25.8M |
|
999
PUT
Ferrari
RACE
$72.5B
| $48.6M | 0.01% |
265,000
+162,600
| +159% | +$32.4M |
|
|
B
1000
Barrick Mining
B
$67.3B
| $48.5M | 0.01% |
2,744,097
+1,924,020
| +235% | +$41.7M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.